ADA Scientific Sessions 2026 Abstract

Disparities in Sodium–Glucose Cotransporter Inhibitors (SGLTi) Use: A Systematic Literature Review

By Matthew J. Budoff, Keith C. Norris, Anne Peters

ReviewPopulations

The paper

Matthew J. Budoff, Keith C. Norris, Anne Peters

Los Angeles

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1841-P

doi.org/10.2337/db26-1841-p

Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs